Skip to content

gosset deals ​

Search licensing, M&A, collaboration and financing deals by drug, target, disease, party, deal type, value and date.

bash
gosset deals [filters] [output flags]

There is no positional argument; use the filters.

Filters ​

FlagAcceptsExample
--drugdrug name or id--drug pembrolizumab
--targettarget name or id--target TL1A
--diseasedisease name or id; includes narrower diseases--disease "breast cancer"
--buyerbuyer or licensee, name or id--buyer Pfizer
--sellerseller or licensor, name or id--seller "Prometheus Biosciences"
--deal-typedeal type(s)--deal-type Licensing · --deal-type "M&A"
--min-valueminimum total deal value, USD--min-value 1000000000
--since / --untildeal date YYYY-MM-DD--since 2025-01-01

--deal-type takes a deal type as shown in the deal_type field (for example Licensing & Asset Sales, Mergers & Acquisitions, Fundraising) or a short alias: licensing, m&a, acquisition, collaboration, co-development, financing, royalty, option, platform, prv.

Default sort: newest first.

More filters (buyer or seller country, whether a party is listed, the phase of the assets at signing, provenance) are available through --where.

Examples ​

bash
gosset deals --target TL1A --limit 5 --table
date        deal_type                                           buyers                          sellers                    drugs                         upfront_usd
----------  --------------------------------------------------  ------------------------------  -------------------------  ----------------------------  -----------
2026-11-02  Fundraising                                         syndicate of leading healthca…  Caldera Therapeutics       CLD-423                       278000000
2026-10-05  Fundraising                                         Public Market                   Spyre Therapeutics         SPY072
2026-07-29  Licensing & Asset Sales                             Caldera Therapeutics            Qyuns Therapeutics         CLD-423
2026-07-28  Mergers & Acquisitions, Spinouts & Reverse Mergers  Caldera Therapeutics            Synlogic                   CLD-423
2026-06-22  Licensing & Asset Sales                             Bionyra Pharma                  TrueLab Biopharmaceutical  BYN-002, BYN-003, TL-001, …

… showing 5 of 65 total
bash
# Large oncology acquisitions in 2025-2026
gosset deals --disease cancer --deal-type "M&A" --min-value 1000000000 --since 2025-01-01 --limit 5 --table
date        deal_type               buyers      sellers                             drugs                                     upfront_usd
----------  ----------------------  ----------  ----------------------------------  ----------------------------------------  -----------
2026-10-21  Mergers & Acquisitions  Cencora     American Oncology Network                                                     2300000000
2026-10-18  Mergers & Acquisitions  Merck KGaA  Silence Therapeutics                Divesiran                                 1300000000
2026-10-08  Mergers & Acquisitions  Viatris     Pacira BioSciences                  EXPAREL, bupivacaine, ZILRETTA, …         1650000000
2026-09-21  Mergers & Acquisitions  Telix       ITM Isotope Technologies Munich SE  ITM-11, ¹⁷⁷Lu-edotreotide, TLX591, …       1650000000
…
bash
# Licensing deals involving a drug since 2024
gosset deals --drug pembrolizumab --deal-type Licensing --since 2024-01-01 --limit 5 --table

# What a company bought, licensed in or invested in
gosset deals --buyer Pfizer --since 2025-01-01 --limit 5 --table

# A company's history as the seller
gosset deals --seller "Prometheus Biosciences" --table
bash
# TL1A deals where the seller is in China
gosset deals --target TL1A --where seller_country=China \
  --fields date,deal_type,buyers,sellers,upfront_usd --table
date        deal_type                                      buyers                  sellers                       upfront_usd
----------  ---------------------------------------------  ----------------------  ----------------------------  -----------
2026-07-29  Licensing & Asset Sales                        Caldera Therapeutics    Qyuns Therapeutics
2026-06-22  Licensing & Asset Sales                        Bionyra Pharma          TrueLab Biopharmaceutical
…
2025-04-01  Licensing & Asset Sales, Strategic Investment  Caldera Therapeutics    Qyuns Therapeutics            10000000
2024-06-13  Licensing & Asset Sales                        AbbVie                  FutureGen Biopharmaceutical   150000000

Piping to jq ​

buyers and sellers are lists of objects with name, category and country:

bash
# Date, buyers and upfront for recent HER2 licensing deals
gosset deals --target HER2 --deal-type Licensing --since 2025-01-01 --limit 5 \
  | jq -r '.[] | "\(.date)\t\([.buyers[].name] | join(", "))\t\(.upfront_usd // "n/d")"'
2026-10-27	AstraZeneca	n/d
2026-10-14	Biocon	n/d
2026-09-01	AstraZeneca	n/d
2026-08-31	Cipla	n/d
2026-08-31	AstraZeneca	n/d

Useful fields ​

Run gosset schema deals for all of them. Common ones: deal_id, date, deal_type, status, title, summary, terms, buyers, sellers, drugs, drug_phase, diseases, targets, modalities, upfront_usd, max_value_usd, url, provenance_status.

provenance_status tells you what backs a deal: verified means a primary document (an SEC filing or a party's press release) quotes it.

Newly added deals

A deal can appear before its type and parties are filled in. When you don't pass --sort or --offset, gosset deals moves those rows below the complete ones, so the informative deals come first.

Gosset Documentation